The DOI matches its Crossref record; 88 of the 88 references it cites were found in a registry or an index.
Estrogen regulation of apoptosis: how can one hormone stimulate and inhibit?
Open accessAbstract
The link between estrogen and the development and proliferation of breast cancer is well documented. Estrogen stimulates growth and inhibits apoptosis through estrogen receptor-mediated mechanisms in many cell types. Interestingly, there is strong evidence that estrogen induces apoptosis in breast cancer and other cell types. Forty years ago, before the development of tamoxifen, high-dose estrogen was used to induce tumor regression of hormone-dependent breast cancer in post-menopausal women. While the mechanisms by which estrogen induces apoptosis were not completely known, recent evidence from our laboratory and others demonstrates the involvement of the extrinsic (Fas/FasL) and the intrinsic (mitochondria) pathways in this process. We discuss the different apoptotic signaling pathways involved in E2 (17beta-estradiol)-induced apoptosis, including the intrinsic and extrinsic apoptosis pathways, the NF-kappaB (nuclear factor-kappa-B)-mediated survival pathway as well as the PI3K (phosphoinositide 3-kinase)/Akt signaling pathway. Breast cancer cells can also be sensitized to estrogen-induced apoptosis through suppression of glutathione by BSO (L-buthionine sulfoximine). This finding has implications for the control of breast cancer with low-dose estrogen and other targeted therapeutic drugs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Estradiol Rapidly Activates Akt via the ErbB2 Signaling Pathway
Stoica, G. E., Franke, T. F., Wellstein, A., Czubayko, F., List, H.-J., Reiter, R., Morgan, E., Martin, M. B., & Stoica, A. (2003) · Molecular Endocrinology · doi:10.1210/me.2002-0330 · Cited by 118
RetractedHanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Writing Group for the Women's Health Initiative Investigators (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.3.321 · Cited by 15,889
Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery
Datta, S. R., Dudek, H., Tao, X., Masters, S., Fu, H., Gotoh, Y., & Greenberg, M. E. (1997) · Cell · doi:10.1016/s0092-8674(00)80405-5 · Cited by 5,689
NF-κB AND REL PROTEINS: Evolutionarily Conserved Mediators of Immune Responses
Ghosh, S., May, M. J., & Kopp, E. B. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.225 · Cited by 5,182
Tamoxifen for early breast cancer: an overview of the randomised trials
(1998) · The Lancet · doi:10.1016/s0140-6736(97)11423-4 · Cited by 4,085
Breast cancer and hormone-replacement therapy in the Million Women Study
(2003) · The Lancet · doi:10.1016/s0140-6736(03)14065-2 · Cited by 2,993
Focan, C., Steinberg, S. M., Blichert-Toft, M., Forbes, J., Collins, R. D., Anderson, S., Margreiter, R., Harwood, C. S., Andersen, K., Beighton, G., et al. (1998) · PubMed · Cited by 2,146
Sex Steroids and the Construction and Conservation of the Adult Skeleton
Riggs, B. L., Khosla, S., & Melton, L. J. (2002) · Endocrine Reviews · doi:10.1210/edrv.23.3.0465 · Cited by 1,846
Interleukin-3-Induced Phosphorylation of BAD Through the Protein Kinase Akt
Peso, L. D., González-Garcı́a, M., Page, C., Herrera, R., & Nuñez, G. (1997) · Science · doi:10.1126/science.278.5338.687 · Cited by 1,797
Beatson, G. (1896) · The Lancet · doi:10.1016/s0140-6736(01)72384-7 · Cited by 1,608
Breast cancer and hormone-replacement therapy: the Million Women Study
Beral, V., Banks, E., Reeves, G., & Bull, D. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14596-5 · Cited by 1,273
Degterev, A., Boyce, M., & Yuan, J. (2003) · Oncogene · doi:10.1038/sj.onc.1207107 · Cited by 1,107
The CD95(APO-1/Fas) DISC and beyond
Peter, M. E., & Krammer, P. H. (2003) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401186 · Cited by 1,080
Bcl-2 Inhibitors: Targeting Mitochondrial Apoptotic Pathways in Cancer Therapy
Kang, M. H., & Reynolds, C. P. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0144 · Cited by 1,016
Estrogen Prevents Bone Loss via Estrogen Receptor α and Induction of Fas Ligand in Osteoclasts
Nakamura, T., Imai, Y., Matsumoto, T., Sato, S., Takeuchi, K., Igarashi, K., Harada, Y., Azuma, Y., Krust, A., Yamamoto, Y., et al. (2007) · Cell · doi:10.1016/j.cell.2007.07.025 · Cited by 1,013
A Retroviral Oncogene, akt , Encoding a Serine-Threonine Kinase Containing an SH2-Like Region
Bellacosa, A., Testa, J. R., Staal, S. P., & Tsichlis, P. N. (1991) · Science · doi:10.1126/science.1833819 · Cited by 939
Howell, A. (1998) · PubMed · Cited by 901
Osteoclasts: What Do They Do and How Do They Do It?
Teitelbaum, S. L. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.060834 · Cited by 730
Kasibhatla, S., Brunner, T., Genestier, L., Echeverri, F., Mahboubi, A., & Green, D. R. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80054-4 · Cited by 721
A New Anti-oestrogenic Agent in Late Breast Cancer: An Early Clinical Appraisal of ICI46474
Cole, M. P., Jones, C. T. A., & Todd, I. D. H. (1971) · British Journal of Cancer · doi:10.1038/bjc.1971.33 · Cited by 701
Delmas, P. D., Ensrud, K. E., Adachi, J. D., Harper, K. D., Sarkar, S., Gennari, C., Reginster, J., Pols, H. A. P., Recker, R. R., Harris, S. T., et al. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.8.3609 · Cited by 563
Arpino, G., Wiechmann, L., Osborne, C. K., & Schiff, R. (2008) · Endocrine Reviews · doi:10.1210/er.2006-0045 · Cited by 549
Nature of Functional Estrogen Receptors at the Plasma Membrane
Pedram, A., Razandi, M., & Levin, E. R. (2006) · Molecular Endocrinology · doi:10.1210/me.2005-0525 · Cited by 522
Drug discovery approaches targeting the PI3K/Akt pathway in cancer
Garcia-Echeverria, C., & Sellers, W. R. (2008) · Oncogene · doi:10.1038/onc.2008.246 · Cited by 473
Functional Synergy between the Transcription Factor Sp1 and the Estrogen Receptor
Porter, W. W., Saville, B., Hoivik, D. J., & Safe, S. H. (1997) · Molecular Endocrinology · doi:10.1210/me.11.11.1569 · Cited by 428
Current insights into the regulation of programmed cell death by NF-κB
Dutta, J., Fan, Y., Gupta, N., Fan, G., & Gélinas, C. (2006) · Oncogene · doi:10.1038/sj.onc.1209938 · Cited by 407
Saville, B., Wormke, M., Wang, F., Nguyen, T., Enmark, E., Kuiper, G., Gustafsson, J.-Å., & Safe, S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.8.5379 · Cited by 401
Srivastava, S., Toraldo, G., Weitzmann, M. N., Cenci, S., Ross, F. P., & Pacifici, R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010764200 · Cited by 358
Altucci, L., Addeo, R., Cicatiello, L., Dauvois, S., Parker, M., Truss, M., Beato, M., Sica, V., Bresciani, F., & Weisz, A. (1996) · PubMed · Cited by 343
Role of Hormones in Mammary Cancer Initiation and Progression
Russo, I. H., & Russo, J. (1998) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1023/a:1018770218022 · Cited by 337
Ingle, J. N., Ahmann, D. L., Green, S. J., Edmonson, J. H., Bisel, H. F., Kvols, L. K., Nichols, W. C., Creagan, E. T., Hahn, R. G., Rubin, J., et al. (1981) · New England Journal of Medicine · doi:10.1056/nejm198101013040104 · Cited by 336
O'Brien, S., Moore, J. O., Boyd, T. E., Larratt, L. M., Skotnicki, A., Koziner, B., Chanan-Khan, A. A., Seymour, J. F., Bociek, R. G., Pavletic, S., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.07.1191 · Cited by 303
Influence of Synthetic Oestrogens on Advanced Malignant Disease
Haddow, A., Watkinson, J., Paterson, E., & KOLLER, P. C. (1944) · BMJ · doi:10.1136/bmj.2.4368.393 · Cited by 299
Song, R. X.-D., Mor, G., Naftolin, F., McPherson, R. A., Song, J., Zhang, Z., Yue, W., Wang, J., & Santen, R. J. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.22.1714 · Cited by 293
Ellis, M. J., Gao, F., Dehdashti, F., Jeffe, D. B., Marcom, P. K., Carey, L. A., Dickler, M. N., Silverman, P., Fleming, G. F., Kommareddy, A., et al. (2009) · JAMA · doi:10.1001/jama.2009.1204 · Cited by 287
Jiang, S.-Y., & Jordan, V. C. (1992) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/84.8.580 · Cited by 261
Self-citationLeone, M., Zhai, D., Sareth, S., Kitada, S., Reed, J. C., & Pellecchia, M. (2003) · PubMed · Cited by 259
Schnelldorfer, T., Gansauge, S., Gansauge, F., Schlosser, S., Beger, H. G., & Nussler, A. K. (2000) · Cancer · doi:10.1002/1097-0142(20001001)89:7<1440::aid-cncr5>3.0.co;2-0 · Cited by 246
Foster, J. S. (1996) · Molecular Endocrinology · doi:10.1210/me.10.5.488 · Cited by 244
Lewis, J. S., Meeke, K., Osipo, C., Ross, E. A., Kidawi, N., Li, T., Bell, E., Chandel, N. S., & Jordan, V. C. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji400 · Cited by 244
Self-citationKrishnan, V., Wang, X., & Safe, S. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)40767-8 · Cited by 243
Lønning, P. E., Taylor, P. D., Anker, G., Iddon, J., Wie, L., Jørgensen, L.-M., Mella, O., & Howell, A. (2001) · Breast Cancer Research and Treatment · doi:10.1023/a:1010619225209 · Cited by 226
BCL-2 and glutathione: alterations in cellular redox state that regulate apoptosis sensitivity
Voehringer, D. W. (1999) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(99)00174-4 · Cited by 224
Shift of the Cellular Oxidation‐Reduction Potential in Neural Cells Expressing Bcl‐2
Ellerby, L. M., Ellerby, H. M., Park, S. M., Holleran, A. L., Murphy, A. N., Fiskum, G., Kane, D. J., Testa, M. P., Kayalar, C., & Bredesen, D. E. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.67031259.x · Cited by 223
Estrogen Receptor-Mediated Rapid Signaling
Moriarty, K., Kim, K. H., & Bender, J. R. (2006) · Endocrinology · doi:10.1210/en.2006-0729 · Cited by 205
Duan, R., Porter, W. W., & Safe, S. H. (1998) · Endocrinology · doi:10.1210/en.139.4.1981 · Cited by 199
Induction of Apoptosis by Diethylstilbestrol in Hormone-Insensitive Prostate Cancer Cells
Robertson, C. N., Roberson, K. M., Padilla, G. M., O'Brien, E. T., Cook, J. M., Kim, C.-S., & Fine, R. L. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.13.908 · Cited by 190
Bailey, H. H., Mulcahy, R. T., Tutsch, K. D., Arzoomanian, R. Z., Alberti, D., Tombes, M. B., Wilding, G., Pomplun, M., & Spriggs, D. R. (1994) · Journal of Clinical Oncology · doi:10.1200/jco.1994.12.1.194 · Cited by 188
l-S,R-buthionine sulfoximine: historical development and clinical issues
Bailey, H. H. (1998) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(97)00164-6 · Cited by 178
Hormonal regulation of apoptosis in breast cells and tissues
Gompel, A. (2000) · Steroids · doi:10.1016/s0039-128x(00)00172-0 · Cited by 165
Phase I Study of Continuous-Infusion L-S,R-Buthionine Sulfoximine With Intravenous Melphalan
Bailey, H. H., Ripple, G., Tutsch, K. D., Arzoomanian, R. Z., Alberti, D., Feierabend, C., Mahvi, D., Schink, J., Pomplun, M., Mulcahy, R. T., et al. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.23.1789 · Cited by 164
Apoptotic Action of 17 -Estradiol in Raloxifene-Resistant MCF-7 Cells In Vitro and In Vivo
Liu, H., Lee, E.-S., Gajdos, C., Pearce, S. T., Chen, B., Osipo, C., Loweth, J., McKian, K., Reyes, A. D. L., Wing, L., et al. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djg080 · Cited by 146
Self-citationNilsen, J., Mor, G., & Naftolin, F. N. (2000) · Journal of Neurobiology · doi:10.1002/(sici)1097-4695(200004)43:1<64::aid-neu6>3.0.co;2-7 · Cited by 144
Membrane-Associated Estrogen Receptor Signaling Pathways in Human Cancers
Pietras, R. J., & Márquez‐Garbán, D. C. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1373 · Cited by 144
Osipo, C., Gajdos, C., Liu, H., Chen, B., & Jordan, V. C. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djg079 · Cited by 131
Self-citationActivation of c-Jun N-terminal Kinase Antagonizes an Anti-apoptotic Action of Bcl-2
Park, J., Kim, I. J., Oh, Y. J., Lee, K.-W., Han, P., & Choi, E. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.27.16725 · Cited by 130
Peethambaram, P. P., Ingle, J. N., Suman, V. J., Hartmann, L. C., & Loprinzi, C. L. (1999) · Breast Cancer Research and Treatment · doi:10.1023/a:1006185805079 · Cited by 127
Bcl-2 Family of Proteins: Life-or-Death Switch in Mitochondria
Tsujimoto, Y. (2002) · Bioscience Reports · doi:10.1023/a:1016061006256 · Cited by 123
Estrogen-Induced Retinoic Acid Receptor 1 Gene Expression: Role of Estrogen Receptor-Sp1 Complex
Sun, G., Porter, W. W., & Safe, S. H. (1998) · Molecular Endocrinology · doi:10.1210/mend.12.6.0125 · Cited by 123
Estrogen-induced apoptosis in a breast cancer model resistant to long-term estrogen withdrawal
Lewis, J. S., Osipo, C., Meeke, K., & Jordan, V. C. (2005) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2004.12.032 · Cited by 120
Self-citationEvidence for estradiol-induced apoptosis and dysregulated T cell maturation in the thymus
Okasha, S., Ryu, S., Do, Y., McKallip, R. J., Nagarkatti, M., & Nagarkatti, P. S. (2001) · Toxicology · doi:10.1016/s0300-483x(01)00374-2 · Cited by 114
Anderson, C. P., Tsai, J. M., Meek, W. E., Liu, R.-M., Tang, Y., Forman, H. J., & Reynolds, C. P. (1999) · Experimental Cell Research · doi:10.1006/excr.1998.4303 · Cited by 113
Transfection of human estrogen receptor (ER) cDNA into ER-negative mammalian cell lines
Levenson, A. S., & Jordan, V. C. (1994) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(94)90035-3 · Cited by 109
Self-citationJordan, V. C. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.17.5190 · Cited by 107
Self-citationTherapeutic targeting of apoptosis pathways in cancer
Ziegler, D. S., & Kung, A. L. (2008) · Current Opinion in Oncology · doi:10.1097/cco.0b013e3282f310f6 · Cited by 94
Growth Factor Signaling in Cell Survival: Implications for Cancer Treatment
Talapatra, S., & Thompson, C. B. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29451-9 · Cited by 93
Santen, R. J., Jeng, M., Wang, J., Song, R. X.-D., Masamura, S., McPherson, R., Santner, S. J., Yue, W., & Shim, W.-S. (2001) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(01)00151-0 · Cited by 89
Zeitlin, B. D., Zeitlin, I. J., & Nor, J. E. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.7693 · Cited by 87
Mor, G., Kohen, F., García-Velasco, J. A., Nilsen, J., Brown, W., Song, J. H., & Naftolin, F. N. (2000) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(00)00081-9 · Cited by 84
Sp1 Phosphorylation Regulates Apoptosis via Extracellular FasL-Fas Engagement
Kavurma, M. M., Santiago, F. S., Bonfoco, E., & Khachigian, L. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009251200 · Cited by 84
Role of Jun and Jun kinase in resistance of cancer cells to therapy
Vasilevskaya, I. A., & O'Dwyer, P. J. (2003) · Drug Resistance Updates · doi:10.1016/s1368-7646(03)00043-8 · Cited by 82
Regulation of Estrogenic Effects by Beclin 1 in Breast Cancer Cells
John, S., Nayvelt, I., Hsu, H., Yang, P., Liu, W., Das, G. M., Thomas, T., & Thomas, T. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5875 · Cited by 80
Glutathione and Drug Resistance
Schroder, C. P., Godwin, A. K., O'Dwyer, P. J., Tew, K. D., Hamilton, T. C., & Ozols, R. F. (1996) · Cancer Investigation · doi:10.3109/07357909609018891 · Cited by 79
Stable transfection of protein kinase C alpha cDNA in hormone-dependent breast cancer cell lines
Tonetti, D. A., Chisamore, M. J., Grdina, W. L., Schurz, H., & Jordan, V. C. (2000) · British Journal of Cancer · doi:10.1054/bjoc.2000.1326 · Cited by 74
Self-citationSanten, R. J., Song, R. X.-D., Masamura, S., et al. (2008) · Advances in experimental medicine and biology · doi:10.1007/978-0-387-78818-0_2 · Cited by 67
Lewis-Wambi, J. S., Kim, H. R., Wambi, C. O., Patel, R. R., Pyle, J. R., Klein–Szanto, A. J., & Jordan, V. C. (2008) · Breast Cancer Research · doi:10.1186/bcr2208 · Cited by 67
Self-citationDiethylstilbestrol: Recommended Dosages for Different Categories of Breast Cancer Patients
Carter, A. C. (1977) · JAMA · doi:10.1001/jama.1977.03270460065023 · Cited by 64
Chisamore, M. J., Ahmed, Y., Bentrem, D. J., Jordan, V. C., & Tonetti, D. A. (2001) · PubMed · Cited by 60
Self-citationSong, R., Zhang, Z., Mor, G., & Santen, R. J. (2005) · APOPTOSIS · doi:10.1007/s10495-005-1903-2 · Cited by 56
Estradiol inhibits adhesion and promotes apoptosis in murine osteoclasts in vitro
Saintier, D., Khanine, V., Uzan, B., Ea, H., de Vernejoul, M. C., & Cohen-Solal, M. E. (2006) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2006.01.009 · Cited by 56
Antisense Strategies for Oncogene Inactivation
Stein, C., Benimetskaya, L., & Mani, S. (2005) · Seminars in Oncology · doi:10.1053/j.seminoncol.2005.09.003 · Cited by 44
Jordan, V. C., Lewis, J. S., Osipo, C., & Cheng, D. (2005) · The Breast · doi:10.1016/j.breast.2005.08.022 · Cited by 40
Self-citationCurrent topics and perspectives on the use of aromatase inhibitors in the treatment of breast cancer
Iwase, H. (2008) · Breast Cancer · doi:10.1007/s12282-008-0071-y · Cited by 36
JNK pathway regulates estradiol-induced apoptosis in hormone-dependent human breast cancer cells
Altıok, N., Koyutürk, M., & Altiok, S. (2006) · Breast Cancer Research and Treatment · doi:10.1007/s10549-006-9451-1 · Cited by 32
Zhang, Y., Zhao, H., Asztalos, S., Chisamore, M. J., Sitabkhan, Y., & Tonetti, D. A. (2009) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-08-0415 · Cited by 32
Swaby, R. F., & Jordan, V. C. (2008) · Clinical Breast Cancer · doi:10.3816/cbc.2008.n.012 · Cited by 24
Self-citationEllis, M., Dehdahti, F., Kommareddy, A., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.sabcs-16 · Cited by 10
Cited by
Manson, J. E., Chlebowski, R. T., Stefanick, M. L., Aragaki, A. K., Rossouw, J. E., Prentice, R. L., Anderson, G., Howard, B. V., Thomson, C. A., LaCroix, A. Z., et al. (2013) · JAMA · doi:10.1001/jama.2013.278040 · Cited by 1,650
MicroRNAs in Development and Disease
Sayed, D., & Abdellatif, M. (2011) · Physiological Reviews · doi:10.1152/physrev.00006.2010 · Cited by 1,078
Sex Hormones in Acquired Immunity and Autoimmune Disease
Moulton, V. R. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02279 · Cited by 620
Anderson, G. L., Chlebowski, R. T., Aragaki, A. K., Kuller, L. H., Manson, J. E., Gass, M., Bluhm, E., Connelly, S., Hubbell, F. A., Lane, D., et al. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70075-x · Cited by 364
Liang, J., & Shang, Y. (2013) · Annual Review of Physiology · doi:10.1146/annurev-physiol-030212-183708 · Cited by 314
Metadata
- Authors
- Lewis-Wambi, J. S., & Jordan, V. C.
- Venue
- Breast Cancer Research
- Published
- 2009-05-29
- Volume
- 11
- Issue
- 3
- Pages
- 206-206
- ISSN
- 1465-5411 (ISSN-L)
- 1465-542X
- OpenAlex
- W2086075884
- Cited by
- 267
- References
- 88
- FWCI
- 11.58
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.